Adaptive Biotechnologies Corp 10-Q for FY2026 Q3
Adaptive Biotechnologies Corp (ADPT)
10-Q
2026-11-04
For: 2026-09-30
View Original
Added on
November 04, 2026
About this 10-Q
Adaptive Biotechnologies Corp filed this 10-Q on November 4, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Adaptive Biotechnologies Corporation recognized $226.3 million of revenue for the nine months ended September 30, 2026, while net loss attributable to the company was $56.9 million. Cash, cash equivalents and marketable securities totaled $400.2 million. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $83.9M
- down 10.7% from $93.97M a year earlier
- Net income
- $2.88M
- down 69.9% from net income of $9.55M a year earlier
- Diluted EPS
- $0.02
- down 66.7% from $0.06 a year earlier